Arbuthnot Banking Group PLC (AQU:ARBN)

Market Cap	166.54M
Revenue (ttm)	172.31M
Net Income (ttm)	16.36M
Shares Out	n/a
EPS (ttm)	1.00
PE Ratio	10.18
Forward PE	9.16
Dividend	0.51 (0.07%)
Ex-Dividend Date	Aug 28, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	775.00
Day's Range	n/a
52-Week Range	640.12 - 775.00
Beta	n/a
RSI	100.00
Earnings Date	Jul 22, 2025

About Achilles Therapeutics

Arbuthnot Banking Group PLC, together with its subsidiaries, provides private and commercial banking products and services in the United Kingdom. The company operates through Banking, Wealth Management, RAF, ACABL, AAG, All Other Divisions, and Group Center segments. It offers private and commercial banking services, including current and deposit accounts, loans, overdrafts, guarantees, charge cards, foreign exchange, mortgage portfolio service, bespoke commercial banking services, and tailored secured lending against property investments and o...

• Industry: Commercial Banks
• Founded: 1833
• Employees: 883
• Stock Exchange: Aquis Exchange
• Ticker Symbol: ARBN

Financial Performance

In 2024, Arbuthnot Banking Group's revenue was 174.93 million, a decrease of -1.86% compared to the previous year's 178.25 million. Earnings were 24.85 million, a decrease of -29.75%.